ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 15.1 | 7.4 | 7.8 |
| Other income | 0.4 | 0.0 | 0.3 |
| Total income | 15.5 | 7.4 | 8.1 |
| Profit before exceptional items & tax | -0.2 | 0.8 | -7.0 |
| Profit before tax | -0.2 | 0.8 | -7.0 |
| Net profit | 1.3 | 0.7 | -7.1 |
| Operating margin | -1.3% | 10.8% | -86.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | +85.70% |
|---|---|
| Revenue, year on year | +93.60% |
BSE results filing, NSE: SAMPRE. Figures extracted from the filing.
Sampre Nutritions Ltd: key numbers
- Share price
- ₹4.09
- Market cap
- ₹36.47 Cr
- Revenue (annual)
- ₹43.35 Cr
- Net profit (annual)
- ₹3.08 Cr
- P/E (TTM)
- 12.5×Sector 41.3×
- Promoter holding
- 14.04%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sampre Nutritions Ltd
All →Sampre Nutritions Q2 FY27 Results: Net Profit ₹0.5 Cr, Down 44.4% YoY
Sampre Nutritions Ltd reported revenue from operations of ₹13.3 Cr (+33.0% YoY) and net profit of ₹0.5 Cr (-44.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.5 Cr · -44.4% YoY
Sampre Nutritions Board Meeting Date
Sampre Nutritions has scheduled a board meeting on 6 November 2026 to consider its unaudited Q2 FY27 standalone and consolidated results. The filing is an advance notice with no results figures yet disclosed.
Sampre Nutritions Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31 of SEBI Listing Regulations.
Sampre Nutritions Capital Structure Change
Sampre Nutritions allotted 1,770,710 equity shares at ₹42 each to promoters upon unsecured loan conversion. This capital issuance totals ₹7.44 Crore.
- Value
- ₹7.44 Cr
Sampre Nutritions Annual General Meeting
Sampre Nutritions Limited conducted its 35th Annual General Meeting on September 4, 2026. Shareholders considered the adoption of financial statements and a revision in director remuneration.
Sampre Nutritions Capital Structure Change
Sampre Nutritions received BSE in-principal approval for a preferential issue of 17.71 lakh equity shares. The issue involves converting ₹7.44 Crore of unsecured loans into equity.
- Value
- ₹7.44 Cr